Heterogeneity of a Herpes Simplex Virus Clinical Isolate Exhibiting Resistance to Acyclovir and Foscarnet
Resistance of herpes simplex virus to acyclovir is a problem of growing clinical importance. Acyclovir-resistance can be due either to mutations in the viral thymidine kinase gene or in the viral DNA polymerase gene. Although clinical resistance has most frequently been associated with thymidine kinase alterations, heterogeneity in clinical isolates has not been addressed frequently. The potential for such heterogeneity has been emphasized by a report describing a pathogenic clinical isolate containing within its population at least one thymidine kinase-proficient DNA polymerase mutant as well as mutants exhibiting thymidine kinase-deficiency (Sacks, et al., 1989). We provide here additional characterization of this isolate and speculations regarding its significance.
KeywordsHerpes Simplex Virus Type Thymidine Kinase Herpes Simplex Virus Thymidine Kinase Thymidine Kinase Activity Plaque Reduction Assay
Unable to display preview. Download preview PDF.
- Ellis, M.N., Waters, R., Hill, E.L., Lober, D.C., Selleseth, D.W., and Barry, D.W., 1989, Orofacial infection of athymic mice with defined mixtures of acyclovirsusceptible and acyclovir-resistant herpes simplex virus type 1, Antimicrob. Agents Chemother. Google Scholar
- Hicks, K.A., and Coen, D.M., unpublished results.Google Scholar
- Larder, B.A., and Darby, G., Virus drug resistance: mechanisms and consequences, Antiviral Res. 4:1–42.Google Scholar
- Pelosi, E., Tyler, K.L., Hwang, C.B.C., and Coen, D.M., manuscript in preparation.Google Scholar